The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $3.08

Today's change0.00 0.00%
Updated July 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Harvard Bioscience Inc

Nasdaq: HBIO
Last

(U.S.) $3.08

Today's change0.00 0.00%
Updated July 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

Harvard Bioscience Inc closed at (U.S.)$3.08.

Over the last five days, shares have lost 0.65% and are down 11.24% for the last year to date. This security has underperformed the S&P 500 by 40.54% during the last year.

Key company metrics

  • Open(U.S.) $3.11
  • Previous close(U.S.) $3.08
  • High(U.S.) $3.22
  • Low(U.S.) $3.02
  • Bid / Ask-- / --
  • YTD % change-11.24%
  • Volume57,500
  • Average volume (10-day)67,901
  • Average volume (1-month)171,842
  • Average volume (3-month)124,193
  • 52-week range(U.S.) $2.41 to (U.S.) $5.13
  • Beta1.10
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.60×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.54
Updated July 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.36%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue27282629
Total other revenue--------
Total revenue27282629
Gross profit13131213
Total cost of revenue14151416
Total operating expense27282729
Selling / general / administrative11101010
Research & development1212
Depreciation / amortization1111
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income00-10
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax00-10
Income after tax-1-17-10
Income tax, total0170-1
Net income-1-17-10
Total adjustments to net income--------
Net income before extra. items-1-17-10
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1-17-10
Inc. avail. to common incl. extra. items-1-17-10
Diluted net income-1-17-10
Dilution adjustment----00
Diluted weighted average shares34343435
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.50-0.020.01
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.02-0.50-0.020.01